The inhalation company Inhalation Sciences has received several new IRS orders from returning global pharmaceutical companies, with a total value of approximately EUR 52,000, corresponding to about SEK 554,000, according to a press release. The orders concern the company's technology platforms PreciseInhale and DissolvIt for controlled inhalation in preclinical research. According to the company, the orders reflect continued interest from existing customers in step with increasing regulatory requirements for more precise test methods.